Sunday, November 1, 2026

Tariffs Bite: Korean Auto and Petrochemical Giants Post Sharp Q2 Declines

South Korean companies face negative revenue growth for the first time in two years, impacting profitability across sectors.

Walmart Report Triggers Stock Market Drop, EV Stocks Hit Hard

U.S. stock market drops as Walmart's report impacts Tesla and other EV stocks, fueled by protests against CEO Musk's actions.

After U.S. Hits Iran, North Korea Boosts Its Own Nuclear Plans

North Korea is likely to enhance its nuclear capabilities in response to U.S. airstrikes on Iran, fearing similar actions against itself.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

FDA Adjusts Drug Review Fees: Higher for New Drugs, Lower for Generics

The FDA’s 2027 fee changes lower review costs for new drugs and biosimilars while raising fees for generics and medical devices, with the impact varying by company.

GIST Develops “Alpha DTA” AI Model to Accurately Predict Drug Candidate Potency

GIST's AI model 'Alpha DTA' predicts drug-target protein binding affinity without experimental verification, enhancing drug discovery.

Shaperon Accelerates Global Commercialization of NuGel…Secures U.S. Patent, Prepares for Licensing Deal

Sharperon accelerates global commercialization of its key atopic dermatitis treatment, NuGel.

“Why Can’t Stem Cell Treatments Be Offered in Korea?”…Government Maps Out a “Korean Model of Regenerative Medicine”

The debate over stem cell therapy highlights why it's available in Japan but not in South Korea.

Yuhan Corp., Celltrion and LigaChem Bio…K-Pharma Firms Move to Boost Corporate Value

The pharmaceutical and biotech sectors are boosting shareholder trust and corporate value through stock buybacks and retirements.

PenetriumBioScience Files U.S. FDA IND for Phase 2a Trial in Advanced Solid Tumors

Penitrium Bioscience enters Phase 2a clinical trials in the U.S. for its cancer drug candidate 'Penitrium.'

DigmBio Launches Preclinical Research for Alzheimer’s Drug DM3159: What You Need to Know

DigmBio has been selected for the R&D project to advance preclinical research on the Alzheimer's drug candidate DM3159.

How DEEPNOID’s AxonFlow is Enhancing Hospital Operations: A Comprehensive Guide

DEEPNOID has received FDA approval for its remote reading platform, AxonFlow, aiding hospitals and screening centers.

SkyLabs’ CART BP Pro: The Revolutionary Ring-Style Blood Pressure Monitor Set to Gain FDA Approval in 2027

Skylabs accelerates its U.S. market entry by starting clinical trials for its ring-shaped blood pressure monitor, seeking FDA approval.

5 Key Research Findings on Dr. Noon CVD: A Game-Changer for Cardiovascular Disease Prevention

Mediwhale presented five abstracts on its AI-based cardiovascular risk assessment solution, Dr. Noon CVD, at the ASPC conference.

“Improved Survival Rates”… Carboplatin Combination Therapy Shows Benefit in Triple-Negative Breast Cancer

Adding carboplatin to chemotherapy for operable triple-negative breast cancer reduces recurrence risk and improves survival, study finds.

Inventage Lab Selected for Global TIPS Program, Accelerating Late-Stage Development of Addiction Treatment

Inventis Lab's long-acting drug IVL3004 for addiction treatment has been selected for the Global TIPS research project by the Ministry of SMEs.

Bukwang Pharm Signs Export Agreement With Thailand’s Pacific Healthcare for Dexid

Bukwang Pharmaceutical signs exclusive export contract for diabetes treatment 'Dexide' with Pacific Healthcare in Thailand.

Huawei Unveils OpenPangu 2.0 Pro: Is This the Future of AI with 505 Billion Parameters?

Huawei accelerates its AI ecosystem expansion by revealing the source of its massive AI model with over 500 billion parameters.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.